BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahmed I, Thorpy M. Clinical Features, Diagnosis and Treatment of Narcolepsy. Clinics in Chest Medicine 2010;31:371-81. [DOI: 10.1016/j.ccm.2010.02.014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Black J, Swick T, Bogan R, Lai C, Carter LP. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy. Sleep Medicine 2016;24:57-62. [DOI: 10.1016/j.sleep.2016.07.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
2 Prasad B, Choi YK, Weaver TE, Carley DW. Pupillometric assessment of sleepiness in narcolepsy. Front Psychiatry 2011;2:35. [PMID: 21713070 DOI: 10.3389/fpsyt.2011.00035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
3 Thorpy MJ. Classification of sleep disorders. Neurotherapeutics 2012;9:687-701. [PMID: 22976557 DOI: 10.1007/s13311-012-0145-6] [Cited by in Crossref: 157] [Cited by in F6Publishing: 113] [Article Influence: 17.4] [Reference Citation Analysis]
4 Bogan RK, Feldman N, Emsellem HA, Rosenberg R, Lu Y, Bream G, Khayrallah M, Lankford DA. Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy. Sleep Med 2015;16:1102-8. [PMID: 26298786 DOI: 10.1016/j.sleep.2015.05.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
5 Rosenbaum AM, Giacino JT. Clinical management of the minimally conscious state. Traumatic Brain Injury, Part I. Elsevier; 2015. pp. 395-410. [DOI: 10.1016/b978-0-444-52892-6.00025-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 Duffy J, Weintraub E, Vellozzi C, DeStefano F; Vaccine Safety Datalink. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology 2014;83:1823-30. [PMID: 25320099 DOI: 10.1212/WNL.0000000000000987] [Cited by in Crossref: 51] [Cited by in F6Publishing: 18] [Article Influence: 6.4] [Reference Citation Analysis]
7 Nirogi R, Ajjala DR, Prakash Padala NS, Kalaikadhiban I, Rayapati LP, Chunduru P, Shinde A. LC-MS/MS method for the quantification of SUVN-G3031, a novel H3 receptor inverse agonist for narcolepsy treatment. Bioanalysis 2020;12:533-44. [PMID: 32351118 DOI: 10.4155/bio-2020-0020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Gamaldo CE, Chung Y, Kang YM, Salas RM. Tick-tock-tick-tock: the impact of circadian rhythm disorders on cardiovascular health and wellness. J Am Soc Hypertens 2014;8:921-9. [PMID: 25492836 DOI: 10.1016/j.jash.2014.08.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
9 Plazzi G, Clawges HM, Owens JA. Clinical Characteristics and Burden of Illness in Pediatric Patients with Narcolepsy. Pediatric Neurology 2018;85:21-32. [DOI: 10.1016/j.pediatrneurol.2018.06.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
10 Destefano F, Offit PA, Fisher A. Vaccine Safety. Plotkin's Vaccines. Elsevier; 2018. pp. 1584-1600.e10. [DOI: 10.1016/b978-0-323-35761-6.00082-1] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
11 Haleem DJ. Extending therapeutic use of psychostimulants: Focus on serotonin-1A receptor. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2013;46:170-80. [DOI: 10.1016/j.pnpbp.2013.07.015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
12 Marques TM, Van Rumund A, Kuiperij HB, Verbeek MM. Biomarkers in cerebrospinal fluid for synucleinopathies, tauopathies, and other neurodegenerative disorders. Cerebrospinal Fluid in Neurologic Disorders. Elsevier; 2018. pp. 99-113. [DOI: 10.1016/b978-0-12-804279-3.00007-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sieminski M, Chwojnicki K, Sarkanen T, Partinen M. The relationship between orexin levels and blood pressure changes in patients with narcolepsy. PLoS One 2017;12:e0185975. [PMID: 29023559 DOI: 10.1371/journal.pone.0185975] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
14 Hu S, Singh M, Wong J, Auckley D, Hershner S, Kakkar R, Thorpy MJ, Chung F. Anesthetic Management of Narcolepsy Patients During Surgery: A Systematic Review. Anesth Analg 2018;126:233-46. [PMID: 29257771 DOI: 10.1213/ANE.0000000000002228] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 2.8] [Reference Citation Analysis]
15 Viorritto EN, Kureshi SA, Owens JA. Narcolepsy in the Pediatric Population. Curr Neurol Neurosci Rep 2012;12:175-81. [DOI: 10.1007/s11910-011-0246-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
16 Krahn LE, Zee PC, Thorpy MJ. Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know. Adv Ther 2022;39:221-43. [PMID: 34894325 DOI: 10.1007/s12325-021-01992-4] [Reference Citation Analysis]
17 Bollaerts K, Shinde V, Dos Santos G, Ferreira G, Bauchau V, Cohet C, Verstraeten T. Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix™ and Narcolepsy. PLoS One 2016;11:e0149289. [PMID: 26901063 DOI: 10.1371/journal.pone.0149289] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
18 Yamamoto K, Kobayashi F, Hori R, Arita A, Sasanabe R, Shiomi T. Association between pupillometric sleepiness measures and sleep latency derived by MSLT in clinically sleepy patients. Environ Health Prev Med 2013;18:361-7. [PMID: 23420264 DOI: 10.1007/s12199-013-0331-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
19 Tsai TF, Crucitti A, Nacci P, Nicolay U, Della Cioppa G, Ferguson J, Clemens R. Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy. Scand J Infect Dis 2011;43:702-6. [PMID: 21534891 DOI: 10.3109/00365548.2011.580777] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
20 Bhattarai J, Sumerall S. Current and Future Treatment Options for Narcolepsy: A Review. Sleep Sci 2017;10:19-27. [PMID: 28966734 DOI: 10.5935/1984-0063.20170004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
21 Kallweit U, Schmidt M, Bassetti CL. Patient-Reported Measures of Narcolepsy: The Need for Better Assessment. J Clin Sleep Med 2017;13:737-44. [PMID: 28162143 DOI: 10.5664/jcsm.6596] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
22 Dauvilliers Y, Shapiro C, Mayer G, Lammers GJ, Emsellem H, Plazzi G, Chen D, Carter LP, Lee L, Black J, Thorpy MJ. Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial. CNS Drugs 2020;34:773-84. [PMID: 32588401 DOI: 10.1007/s40263-020-00744-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Sieminski M, Partinen M. "Non-dipping" is equally frequent in narcoleptic patients and in patients with insomnia. Sleep Biol Rhythms 2016;14:31-6. [PMID: 26855609 DOI: 10.1007/s41105-015-0004-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
24 Aydinoz S, Huang YS, Gozal D, Inocente CO, Franco P, Kheirandish-Gozal L. Allergies and Disease Severity in Childhood Narcolepsy: Preliminary Findings. Sleep 2015;38:1981-4. [PMID: 25902808 DOI: 10.5665/sleep.5254] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
25 Wu S, Wang R, Ma X, Zhao Y, Yan X, He J. Excessive daytime sleepiness assessed by the Epworth Sleepiness Scale and its association with health related quality of life: a population-based study in China. BMC Public Health 2012;12:849. [PMID: 23039935 DOI: 10.1186/1471-2458-12-849] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
26 Gulyani S, Salas RE, Gamaldo CE. Sleep medicine pharmacotherapeutics overview: today, tomorrow, and the future (part 2: hypersomnia, parasomnia, and movement disorders). Chest 2013;143:242-51. [PMID: 23276849 DOI: 10.1378/chest.12-0561] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Hillman DR. Postoperative Sleep Disturbances. Advances in Anesthesia 2017;35:1-24. [DOI: 10.1016/j.aan.2017.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
28 Kachooei-Mohaghegh-Yaghoobi L, Rezaei-Rad F, Sadeghniiat-Haghighi K, Zamani M. The impact of the HLA DQB1 gene and amino acids on the development of narcolepsy. Int J Neurosci 2020;:1-8. [PMID: 33045884 DOI: 10.1080/00207454.2020.1835903] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Parmar A, Murray BJ, Narang I. Clinical Characteristics of Cataplectic Attacks in Type 1 Narcolepsy. Curr Neurol Neurosci Rep 2020;20:38. [PMID: 32651734 DOI: 10.1007/s11910-020-01057-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lividini A, Pizza F, Filardi M, Vandi S, Ingravallo F, Antelmi E, Bruni O, Cosentino FII, Ferri R, Guarnieri B, Marelli S, Ferini-Strambi L, Romigi A, Bonanni E, Maestri M, Terzaghi M, Manni R, Plazzi G. Narcolepsy type 1 features across the life span: age impact on clinical and polysomnographic phenotype. J Clin Sleep Med 2021;17:1363-70. [PMID: 33666167 DOI: 10.5664/jcsm.9198] [Reference Citation Analysis]
31 Miller EE, Grosberg BM, Crystal SC, Robbins MS. Auditory hallucinations associated with migraine: Case series and literature review. Cephalalgia 2015;35:923-30. [DOI: 10.1177/0333102414563088] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
32 Wijnans L, Lecomte C, de Vries C, Weibel D, Sammon C, Hviid A, Svanström H, Mølgaard-Nielsen D, Heijbel H, Dahlström LA, Hallgren J, Sparen P, Jennum P, Mosseveld M, Schuemie M, van der Maas N, Partinen M, Romio S, Trotta F, Santuccio C, Menna A, Plazzi G, Moghadam KK, Ferro S, Lammers GJ, Overeem S, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2013;31:1246-54. [PMID: 23246544 DOI: 10.1016/j.vaccine.2012.12.015] [Cited by in Crossref: 159] [Cited by in F6Publishing: 140] [Article Influence: 15.9] [Reference Citation Analysis]